Consolidated Statements of Operations (USD $)	3 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Revenues	$ 0	$ 0
Operating expenses:
General and administrative expenses	870,355	523,443
Research and development expenses	399,735	257,233
Total operating expenses	1,270,090	780,676
Operating loss	(1,270,090)	(780,676)
Other income (expense):
Interest expense	(27,765)	(27,765)
Gain on exercise of warrants	224,000	0
Loss on warrant derivative modification	(1,300,170)	0
Adjustment to fair value of derivative	2,753,170	0
Total other income (expense)	1,649,235	(27,765)
Net Income (Loss)	$ 379,145	$ (808,441)
Basic earnings per share
Net Income (Loss) per Share	$ 0.01	$ (0.01)
Weighted Common Shares - Basic and Diluted	73,337,085	60,145,237
Diluted earnings per share
Net Income (Loss) per Share	$ 0.01	$ (0.01)
Weighted Common Shares - Diluted	73,422,007	60,145,237